Cannabis Use Disorder and Residential Treatment: The Two-Week Withdrawal Window, Hyperemesis, and What to Tell Admissions

,
Two chairs in a living-room-style therapy space — EMDR trauma processing in residential addiction treatment

“It’s just weed” is one of the most common phrases on an admissions call, and it usually comes from someone who has already tried to stop on their own and could not get through the first week. In California, where adult-use cannabis has been legal for people 21 and older since 2016, it can feel strange to ask for residential treatment for something sold in a storefront. Legal status does not change the diagnosis, though, and it does not change what the first two weeks off a daily habit feel like.

This guide covers how cannabis use disorder is assessed, what withdrawal actually involves, why cannabinoid hyperemesis syndrome matters for planning, and the specific details admissions needs from you so the first days of residential treatment are built around your real pattern of use.

Cannabis Withdrawal in Residential Treatment: The Short Answer

Cannabis withdrawal is real and it is usually not medically dangerous on its own, but it is uncomfortable enough to drive relapse. According to the National Institute on Drug Abuse, cannabis withdrawal symptoms such as irritability, poor sleep, low appetite, restlessness, and cravings typically peak within the first week after stopping and can last up to two weeks. There is currently no FDA-approved medication for cannabis use disorder, so residential care for cannabis focuses on managing sleep, appetite, anxiety, and cravings through those first 14 days while therapy addresses why use became daily. The planning changes significantly if alcohol or benzodiazepines are also being used, because withdrawal from those substances can cause seizures and requires medical supervision.

How Cannabis Use Disorder Is Diagnosed

Clinicians use the DSM-5 criteria for cannabis use disorder, the same 11-criterion framework used for other substances. It includes items such as using more than intended, unsuccessful attempts to cut down, cravings, giving up activities, continued use despite problems, tolerance, and withdrawal. Two or three criteria within a 12-month period indicate a mild disorder, four or five moderate, and six or more severe.

Residential care is generally considered when the disorder is moderate to severe and outpatient attempts have not held, when there is a co-occurring mental health condition, or when home is not a place where stopping is realistic. That level-of-care decision follows the ASAM Criteria from the American Society of Addiction Medicine, not the substance alone.

Why the First Week Is Harder Than People Expect

Most people who call us are surprised by how much the first several days hurt. The mechanisms are fairly consistent:

  • Sleep rebound: Many daily users rely on cannabis to fall asleep, and stopping often brings insomnia and vivid, intense dreams for several nights.
  • Appetite loss: Low appetite and nausea are common early, which matters more for someone who has also had vomiting episodes.
  • Irritability and anxiety: Mood is often at its worst in the first days, and this is when people most often talk themselves into leaving.
  • Concentrate tolerance: People using high-potency vape cartridges or dabs throughout the day tend to describe a rougher withdrawal than people smoking flower occasionally, which is why potency and route are asked about at intake.
  • Conditioned cues: When cannabis has been part of every evening, every drive, or every social plan, cravings are tied to routine as much as to chemistry.

None of this is a reason to avoid treatment. It is the reason a structured setting helps: the hardest days happen where staff can adjust sleep routines, nutrition, and support in real time.

Cannabinoid Hyperemesis Syndrome: The Detail That Changes the Plan

Cannabinoid hyperemesis syndrome (CHS) is a pattern of repeated, severe vomiting episodes in some people with long-term, heavy cannabis use. A recognizable sign is relief from hot showers or baths, sometimes taken many times a day. Episodes can lead to dehydration and emergency department visits. The Centers for Disease Control and Prevention and NIDA both describe vomiting syndromes among the health effects of frequent use.

Stopping cannabis is generally the only lasting treatment for CHS, and symptoms can take time to settle after use ends. If you have had vomiting episodes, ER visits for vomiting, or a habit of long hot showers to feel better, tell admissions. It affects hydration monitoring, whether medical clearance is needed before arrival, and how the first days are staffed.

When Medical Supervision Is Required

Cannabis alone rarely requires medical detox. Combined use is a different matter. If you are also drinking daily or taking benzodiazepines such as alprazolam, clonazepam, or lorazepam, whether prescribed or not, withdrawal from those substances carries a risk of seizures and must be medically supervised. Do not stop alcohol or benzodiazepines abruptly on your own before admission. Tell admissions exactly what you take and how much, and let the clinical team decide whether detox comes first.

Heavy cannabis use, especially high-potency products, can also be associated with psychotic symptoms in some people, according to NIDA’s research report on cannabis. Paranoia, hearing things others do not, or a past psychotic episode should be shared up front so a psychiatric assessment can be arranged. If you or someone you love is in crisis right now, call or text 988, or call 911.

What to Tell Admissions: A Checklist You Can Use Today

Before you call, write down answers to these questions. It takes about ten minutes and makes the assessment more accurate:

  1. Product and route: Flower, vape cartridges, dabs or other concentrates, edibles, or a mix.
  2. Frequency and timing: How many times a day, whether you use on waking, and the date and time of last use.
  3. Other substances: Alcohol, benzodiazepines, sleep medications, stimulants, opioids, or nicotine, with amounts. This is the most important item on the list for safety.
  4. Vomiting history: Any repeated vomiting episodes, ER visits, or relief from hot showers.
  5. Mental health history: Anxiety, depression, panic, paranoia, or any past psychotic symptoms, plus current prescriptions.
  6. Previous attempts to stop: How long you lasted and what made you start again. That answer often shapes the treatment plan more than anything else.
  7. Medical cannabis recommendation: If you have one, say so and name the condition it was for, so the team can plan how that condition will be managed.

Our admissions team can walk through these with you by phone at (877) 328-1968.

What to Ask Admissions

  • How is insomnia handled during the first two weeks, and which sleep medications are and are not used?
  • Is a medical evaluation done on arrival if I have had vomiting episodes or combined alcohol or benzodiazepine use?
  • What therapy approaches are used for cannabis use disorder specifically?
  • Will I see a psychiatric provider if anxiety or mood symptoms are part of the picture?
  • What is my insurance likely to cover? You can start that process through our insurance verification page.

A Note From the Admissions Side

The pattern we see most often is not someone in physical danger from cannabis. It is someone who has stopped many times, made it three or four days, and restarted when sleep fell apart or anxiety spiked. Often there is a second substance in the background, usually alcohol, that nobody mentioned on the first call because the conversation was framed around cannabis. Those are the two facts worth bringing to the phone: how far into withdrawal you have gotten before, and everything else you are taking. They shape the plan more than the amount of cannabis does.

If you are weighing residential care for yourself or a family member, call (877) 328-1968 to talk through the level-of-care questions. You can also contact the free, confidential SAMHSA National Helpline at 1-800-662-4357 for referrals at any time.

This article was written by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i. It is for educational purposes only and is not medical advice, diagnosis, or treatment. Withdrawal from alcohol or benzodiazepines can cause seizures and must be medically supervised. Always consult a qualified healthcare provider about your specific situation. If you are in crisis, call or text 988 or call 911.

/by

Young Adults on a Parent’s Insurance and Residential Treatment: The Age-26 Rule, the Age-18 Privacy Line, and What to Tell Admissions

, ,
A group of people gathered around a table — supporting a loved one during the first weeks of residential rehab

When the person who needs residential treatment is 19, 22 or 25, the phone call to admissions usually comes from a parent. The parent often holds the insurance card, may be paying the deductible, and has watched the last year unfold up close. The young adult, meanwhile, is legally an adult who makes their own medical decisions. Most of the friction we see in admissions for this age group comes from those two facts colliding, not from the clinical picture itself.

This guide walks through the practical side: how coverage on a parent’s plan works, what a parent can and cannot be told once their child is over 18, and what to have ready when you call.

The Short Version: Age 26 for Coverage, Age 18 for Privacy

Under the Affordable Care Act, a young adult can generally stay on a parent’s health plan until age 26, and that plan’s substance use disorder benefits apply to them as a dependent in the same way they apply to the policyholder. Once that young adult turns 18, however, a residential treatment program needs the young adult’s own signed consent before it can share anything about their care with a parent, even when the parent is the policyholder and is paying the bill. Coverage follows the insurance card; information follows the patient’s signature.

Federal confidentiality rules for substance use disorder records, known as 42 CFR Part 2, are stricter than general medical privacy rules. Without a valid written consent, staff generally cannot confirm to a caller that a specific adult is even admitted. Families who learn this on day two often read the silence as the program shutting them out. It is the law working as designed, and it can be addressed before admission rather than after.

Why This Age Group Needs Extra Planning

SAMHSA’s National Survey on Drug Use and Health has consistently found that adults ages 18 to 25 have among the highest rates of substance use disorder of any age group. The National Institute on Drug Abuse also notes that the brain continues developing into the mid-twenties, particularly the regions involved in judgment and impulse control. Those are the clinical reasons this group matters. The logistical reasons are just as real:

  • Split decision-making: The parent controls the insurance and often the money, while the young adult controls consent, so neither can complete admission alone.
  • Thin medical history: Many young adults have no regular primary care doctor, so medication lists, prior diagnoses and past treatment have to be reconstructed at intake.
  • School and work deadlines: A semester withdrawal date or a new job’s probation period creates pressure to delay or shorten care, and that pressure often shows up mid-stay.
  • Underestimated withdrawal risk: Families sometimes assume a young, healthy person can stop anything safely, which is not true for alcohol, benzodiazepines or opioids.

What Happens in the First Week

From the clinical side, the first week for a young adult tends to look different from what parents expect. Many arrive ambivalent, having agreed to come largely because of family pressure. Sleep is often disrupted for several nights. Phone and social media access is usually limited, and for someone in their early twenties that loss can feel larger than the substance itself. It is common for a young adult to call home in the first 72 hours asking to leave. Parents who have talked through that possibility in advance, and agreed together on how they will respond, handle that call far better than parents hearing it cold.

Withdrawal safety does not change with age. Alcohol and benzodiazepine withdrawal can cause seizures and requires medical supervision. Many young adults are using Xanax or other benzodiazepines bought outside a pharmacy, which may be counterfeit and contain different drugs, so an accurate account of what was actually taken matters more than the name on the pill. Opioid withdrawal is rarely life-threatening on its own, but tolerance drops quickly, and returning to use after even a short break carries a serious overdose risk, especially with fentanyl in the supply.

How Insurance on a Parent’s Plan Works

A dependent’s residential treatment is billed under the parent’s policy, so the parent will usually see an Explanation of Benefits. Deductibles and out-of-pocket maximums typically apply at the family level. Prior authorization and ongoing concurrent review generally work the same way they would for the policyholder. Our team can check benefits before anyone commits; start at our insurance verification page or call (877) 328-1968.

Two details catch families off guard. First, California law (Civil Code section 56.107, strengthened by AB 1184) allows a person covered as a dependent to ask their health plan to send communications about sensitive services, which include substance use disorder care, to a different address or by a different method. A young adult may use that right, which means the parent may not receive the paperwork they expect. Second, coverage on a parent’s plan ends at 26. When it ends depends on the plan; many employer plans run through the end of the birthday month, but confirm with the plan. Losing that coverage typically opens a 60-day special enrollment window, through HealthCare.gov or Covered California, so a stay that crosses a 26th birthday needs a coverage plan in place before the birthday arrives.

What to Do Before You Call Admissions

Here are steps a family can take today, before the first call:

  1. Agree on who speaks for whom. If the young adult is willing, they should be on the phone, even briefly. Admissions will need to hear from them directly at some point.
  2. Ask the young adult to sign a consent at intake that names each parent and lists exactly what may be shared: attendance, general progress, discharge date, or the full clinical picture. Narrow consent is still far better than none.
  3. Write down every substance used in the past 30 days, with rough amounts and the date and time of last use. Include pills of uncertain origin.
  4. Gather the insurance card, policyholder date of birth and employer name. If the young adult turns 26 within the next three months, say so on the first call.
  5. List school or work deadlines. A treatment team can often work with a letter for a dean or HR office, but only if they know about the deadline early.

If you want to talk any of this through, reach our admissions team at (877) 328-1968. Calls are confidential.

What We Observe in Practice

Working with families in Northern California, a few patterns come up repeatedly with young adult admissions. The consent conversation goes better when the young adult hears that they control the scope; offering a choice of what to share tends to get a yes, while demanding full access tends to get a refusal. Parents who arrange the 26th-birthday coverage question on day one avoid a mid-stay scramble. And young adults who leave in the first days often return later; the work done on consent, history and insurance is not wasted if that happens.

Residential care for this age group usually includes individual therapy, group therapy with peers, family sessions with consent, and planning for what comes next, including school or work re-entry and step-down care. You can read more about our residential treatment program and how it connects to outpatient treatment after discharge.

If Things Are Urgent Right Now

If your young adult is showing signs of overdose, such as slow or stopped breathing, blue lips or being unresponsive, call 911 and give naloxone if you have it. If they are in emotional crisis or talking about suicide, call or text 988. For free, confidential treatment referral information, the SAMHSA National Helpline is available at 1-800-662-4357, 24 hours a day.

Questions to Ask Admissions

  • What consent form will my child be asked to sign, and can we see it in advance?
  • Who on the clinical team will be the family’s point of contact once consent is in place?
  • How is withdrawal assessed and managed on site, and when would someone be sent to a hospital?
  • How are family sessions scheduled, and are they available remotely?
  • If coverage changes during the stay, how is billing handled?

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Insurance rules and timelines vary by plan; confirm details with your insurer. Never stop alcohol, benzodiazepines or other prescribed medications abruptly without medical supervision.

/by

Ketamine Use and Residential Treatment: No Detox Medication, Bladder Symptoms, Prescribed Ketamine, and What to Tell Admissions

, ,
Crop 0 0 1200 628 0 Featuredimage2 — Bodhi Addiction Treatment & Wellness

Ketamine rarely comes up first on an admissions call. People mention alcohol, pills, or stimulants, and ketamine surfaces ten minutes in, usually described as “not really the problem” or “something my doctor started.” This guide covers what residential treatment actually does when ketamine is part of the picture: how use is assessed, why there is no detox medication for it, what happens to the bladder, how a legitimate ketamine prescription is handled, and exactly what to tell admissions so the first week is planned correctly. If you want to talk it through now, call (877) 328-1968.

The Short Version: How Ketamine Is Classified and Treated

Ketamine is a Schedule III controlled substance under federal law, approved as an anesthetic, and there is no FDA-approved medication for treating ketamine use disorder. Esketamine (Spravato), the FDA-approved nasal spray for treatment-resistant depression, can only be given in a certified healthcare setting, where the patient is monitored for at least two hours after each dose and cannot take the medication home. So when someone has ketamine at home in powder, liquid, or lozenge form, it is either illicit, diverted, or prescribed off-label by a telehealth or clinic prescriber, and residential treatment for problematic ketamine use relies on medical monitoring, symptom management, and behavioral therapy rather than a replacement medication.

How Admissions Decides Whether Ketamine Use Is a Disorder

In the DSM-5, ketamine falls under the phencyclidine-type substances. A use disorder is diagnosed when at least two of the listed criteria occur within a 12-month period: using more than intended, failed attempts to cut down, cravings, giving up activities, continued use despite physical or psychological harm, tolerance, and so on. One difference matters for planning: unlike alcohol or opioids, the criteria list does not include a defined withdrawal syndrome. That does not mean stopping is easy. It means the difficult part is usually psychological rather than a predictable physical withdrawal curve.

A clinician will also use the ASAM Criteria to decide whether residential treatment is the right level of care, looking at medical risk, mental health, readiness, and how safe the home environment is.

Why Ketamine Use Escalates

From the admissions side, these are the patterns that come up again and again. They are clinical observations, not a checklist for self-diagnosis.

  • Fast tolerance: The dissociative effect fades with repeated use, so people take larger amounts or use more often to get the same distance from their thoughts.
  • Dissociation as relief: For someone with depression, anxiety, or trauma, the detached state can feel like the first break in months, which makes it hard to see the use as a problem.
  • The prescription bridge: Some people start with ketamine for depression and begin taking extra doses between sessions or buying more when the supply runs out.
  • Short effect, repeated dosing: The effects wear off relatively quickly, which encourages several doses in a single night.
  • Mixing with depressants: Ketamine is often combined with alcohol or benzodiazepines, which raises the risk of dangerous sedation and slowed breathing.

What the First Week Actually Looks Like

Because there is no standard ketamine detox protocol, the first days in residential care are about watching closely and treating what shows up. People commonly describe low mood, poor or broken sleep, fatigue, irritability, strong cravings, and a flat, foggy feeling sometimes described as “not being back in my body yet.” Families often notice the person sleeping far more than usual early on, then becoming restless and anxious later in the week.

Mood is the part the clinical team watches most closely. When ketamine has been masking depression, that depression can return quickly once use stops. Staff will check in on mood and safety daily and coordinate with psychiatry. If co-occurring depression or anxiety is significant, integrated mental health treatment runs alongside the substance use work rather than after it. The National Institute of Mental Health notes that substance use disorders and mental health conditions frequently occur together and are best treated together.

A safety note that matters more than the ketamine itself: if ketamine has been used alongside daily alcohol or benzodiazepines, withdrawal from those substances can cause seizures and can be life-threatening. That withdrawal requires medical supervision. Do not stop alcohol or benzodiazepines suddenly on your own before admission. Tell admissions exactly how much and how often, so the medical team can plan a supervised taper.

The Bladder Problem Nobody Mentions on the Phone

Regular ketamine use is linked to damage to the bladder and urinary tract, sometimes called ketamine-associated uropathy or ketamine cystitis. Symptoms include needing to urinate very often, urgency, pain when the bladder fills or empties, and blood in the urine. Many people have lived with these symptoms for months and assume they are a recurring urinary tract infection that antibiotics never quite clear.

Stopping ketamine is the most important step, and some people see improvement after they stop, but severe or long-standing damage may need a urologist. A residential medical team can order a urine test, track symptoms, and arrange a referral. Visible blood in the urine, inability to urinate, fever, or severe pain needs prompt medical evaluation, not a wait-and-see approach.

If Your Ketamine Is Prescribed

A legitimate prescription does not disqualify anyone from treatment, and it does not have to be hidden. What admissions needs is the full picture: who prescribes it, the dose, the form, how often it is taken, and whether actual use matches the prescription. If it does match, the medical team will usually contact the prescriber, with your written consent, to decide together whether to pause, continue, or replace it with a different depression treatment during the stay. If use has gone beyond the prescription, say so plainly. It changes the treatment plan, and it is far better for the team to know on day one than to find out on day five.

Do not stop a prescribed depression treatment abruptly before admission without talking to the prescriber first, because mood can drop quickly.

What to Tell Admissions: A Checklist You Can Use Today

Before you or your loved one calls, write these down. It takes about ten minutes and makes the intake assessment much more accurate.

  1. Form and route: powder (snorted), liquid, lozenge, injection, or prescribed nasal or clinic treatment.
  2. Amount and frequency: a typical day or weekend, and the date and time of last use.
  3. Everything else used with it: alcohol, benzodiazepines, opioids, stimulants, cannabis, with amounts for each.
  4. Bladder symptoms: how many times a day you urinate, any pain, and any blood. If you can, keep a simple tally for the next 24 hours.
  5. Mental health history: diagnoses, current medications, and any past suicide attempts or recent thoughts of suicide.
  6. Prescriber details: name, clinic, and phone number if ketamine or esketamine is prescribed.
  7. Insurance card: front and back. You can start a check through our insurance verification page.

Then ask admissions this one question directly: “How will your medical team monitor mood and bladder symptoms in the first week, and who coordinates with my prescriber?” A program that has thought about ketamine will have a specific answer.

For Families: What You Can Do Right Now

Families often see the bathroom trips, the long periods of staring or seeming disconnected, and the mood crashes before the person admits there is a problem. You do not need to prove anything to start a conversation with admissions. Write down what you have observed and when, and call. If the person is unsafe, unresponsive, or talking about suicide, call 911 or the 988 Suicide & Crisis Lifeline by calling or texting 988. For free, confidential treatment referrals at any hour, the SAMHSA National Helpline is available, and the National Institute on Drug Abuse maintains research-based information on substances and treatment.

Getting Started in Northern California

Ketamine use is treatable, and recovery does not depend on a medication that does not exist. It depends on a careful first week, honest information at intake, and treatment that addresses whatever the ketamine was covering up. Our admissions team can walk you through the assessment, insurance, and next steps. Call (877) 328-1968 to speak with someone today.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Withdrawal from alcohol or benzodiazepines can be dangerous and should only happen under medical supervision. If you or someone you know is in crisis, call or text 988 or call 911.

/by

Meth and Cocaine Use Disorder in Residential Treatment: The 2-of-11 Rule, No FDA-Approved Medication, and What to Tell Admissions

, , ,
meth crash

When a family calls about methamphetamine or cocaine, the first question is almost always some version of “Is there a medication for this, like there is for opioids?” The answer shapes everything else about the admissions process, so it is worth starting there. This guide walks through how stimulant use disorder is diagnosed, what the first week of residential treatment actually looks like, why the treatment plan is built around behavioral care rather than a prescription, and what to have ready when you call admissions.

The Short Answer: Diagnosis Rules and the Medication Gap

Stimulant use disorder, which covers methamphetamine, cocaine and misused prescription stimulants, is diagnosed under the DSM-5 when a person meets at least 2 of 11 criteria within a 12-month period; 2 to 3 criteria is classed as mild, 4 to 5 as moderate and 6 or more as severe. Unlike opioid or alcohol use disorder, there is currently no medication approved by the U.S. Food and Drug Administration specifically to treat stimulant use disorder, so residential treatment for meth or cocaine is built mainly on behavioral therapies such as contingency management and cognitive behavioral therapy, with medical and psychiatric care used to manage sleep, mood and any co-occurring conditions.

The National Institute on Drug Abuse (NIDA) describes behavioral therapies, including contingency management, as the most effective treatments currently available for methamphetamine use disorder, and notes that research into medications is ongoing. That is not a weakness of residential care. It is the reason structure, time and a clinical team matter so much more for stimulants than many families expect.

What the First Week Actually Looks Like

Families often brace for a dramatic physical withdrawal. With stimulants alone, what we usually see instead is a crash. Speaking from years of admissions conversations and placements, the pattern in the first several days is remarkably consistent:

  • Days 1 to 3: long stretches of sleep, sometimes 12 hours or more, heavy appetite, irritability and a flat, exhausted mood. Families sometimes worry that their loved one is “doing nothing.” Sleeping is the work at this stage.
  • Days 4 to 7: energy starts to return unevenly. Low mood, anxiety and intense cravings often come in waves, frequently triggered by boredom, a phone call or a memory.
  • Weeks 2 to 4: sleep begins to normalize for many people, but anhedonia, the sense that nothing feels rewarding, can linger. This is the stretch where people most often want to leave, saying “I feel fine now.”

Timelines vary from person to person, and these are clinical observations rather than fixed rules. The key point is that the most dangerous period for leaving early is usually not day one, but the second and third week, when the crash has lifted and the brain’s reward system has not yet recovered.

Why Stimulant Withdrawal Still Needs Clinical Oversight

Withdrawal from stimulants alone is generally not considered physically life-threatening in the way alcohol withdrawal can be. That does not mean it is safe to go it alone. Three mechanisms drive the clinical risk:

Post-crash depression: mood can drop sharply in the days after heavy use stops, and some people experience suicidal thoughts that need same-day psychiatric assessment.

Stimulant-induced psychosis: paranoia, hallucinations or agitation can persist after use stops, particularly after prolonged methamphetamine use, and require medical evaluation rather than waiting it out.

Hidden co-use: many people who use stimulants also use alcohol, benzodiazepines or opioids to come down or sleep, and withdrawal from alcohol and benzodiazepines carries a real risk of seizures that requires medical supervision.

That third point is the inconvenient truth of stimulant admissions. In our experience, the substance a family calls about is often not the one that determines the level of care. A person described as “only using meth” who also drinks every night to sleep may need medically supervised detox before or at the start of residential treatment. Never stop alcohol or benzodiazepines abruptly without a medical team involved.

If you or a loved one is having thoughts of suicide, call or text 988, the Suicide and Crisis Lifeline, or call 911 in an emergency.

How Treatment Is Structured Without a Medication

Because there is no FDA-approved medication, a strong residential program for stimulant use disorder is defined by what it does with the day. When you compare programs, these are the components to look for:

  • Contingency management: a structured system that provides tangible rewards for verified outcomes such as negative drug tests. SAMHSA has supported wider use of contingency management for stimulant use disorders, and it is one of the best-studied approaches available.
  • Cognitive behavioral therapy: practical work on identifying triggers, planning for high-risk situations and handling cravings without acting on them.
  • Psychiatric evaluation: screening for depression, anxiety, ADHD, bipolar disorder and psychosis, since co-occurring conditions are common and can be mistaken for, or masked by, stimulant effects.
  • Sleep and nutrition support: weight loss, dental problems and badly disrupted sleep are common after long stimulant runs, and recovery goes better when the body is rebuilt alongside the mind.
  • Family involvement: education for relatives about the crash, the “I feel fine” phase and what a realistic aftercare plan looks like.

Medications may still be part of a person’s care, for example to treat co-occurring depression or to support sleep, but those decisions belong to the prescribing clinician and are made case by case. You can learn more about how this level of care works on our residential treatment page.

The Fentanyl Factor

The Centers for Disease Control and Prevention (CDC) has reported that a growing share of overdose deaths involving stimulants also involve opioids, particularly illegally made fentanyl. Some of that is intentional co-use, and some is contamination the person never knew about. For admissions, this means two things: the clinical team will want to know about any possible opioid exposure, and the discharge plan should include naloxone and overdose education, because tolerance drops during treatment.

What to Do Before You Call Admissions

The most useful thing you can do today is write down the following before the call, even if the answers are rough estimates. Admissions teams use this to decide whether a person needs detox first, residential care directly, or a different level of care entirely.

  1. Last use: the date and approximate time stimulants were last used.
  2. Pattern: how often, how much and by what route (smoked, snorted, injected), and how long the current run has lasted.
  3. Everything else: every other substance in the past 30 days, especially alcohol, sleeping pills, benzodiazepines such as Xanax or Klonopin, and any opioids.
  4. Sleep: roughly how many hours the person has slept in the last 72 hours.
  5. Mental health: any paranoia, hallucinations, or talk of self-harm or suicide, past or present.
  6. Prescriptions and insurance: a current medication list and an insurance card. You can start the benefits check now through our insurance verification page.

Then ask the program three direct questions: “Do you use contingency management, and how?”, “How do you handle the second and third week, when people want to leave?” and “What does your aftercare plan include for stimulant use?” A program that answers these clearly has thought about stimulant recovery specifically, not just addiction in general.

To talk through a specific situation, call (877) 328-1968.

After Residential: Planning the Step-Down

Cravings for stimulants can resurface weeks or months after the crash has passed, often in response to people, places or even payday. That is why the step-down plan matters as much as the residential stay. Most people benefit from moving into a structured outpatient program rather than going straight home without support, with continued therapy, peer support and, where available, ongoing contingency management.

Recovery from stimulant use disorder is possible, and many people do recover with time and the right structure. If you are trying to figure out the right level of care for yourself or someone you love, our team can walk through the options and the insurance questions with you. Call (877) 328-1968 to speak with someone today.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Withdrawal from alcohol or benzodiazepines can cause seizures and must be medically supervised. If you are experiencing a medical emergency, call 911. If you are in crisis or having thoughts of suicide, call or text 988.

/by

Gambling Problems and Residential Addiction Treatment: The DSM-5 Four-of-Nine Rule, Money Safeguards, and What to Tell Admissions

, ,
Bg1 — Bodhi Addiction Treatment & Wellness

Many people who call us about alcohol or drug treatment are also carrying a second problem they have not mentioned yet: gambling. It usually surfaces late in the admissions call, or in the first week of residential care, when someone finally says how much money is gone, which accounts are overdrawn, or why a family member stopped trusting them with a debit card. This guide explains how gambling problems are screened for during residential treatment, how they are diagnosed, what practical money safeguards help in the first weeks, and exactly what to tell admissions before you arrive.

Gambling Disorder Sits in the Same Diagnostic Chapter as Substance Use

Gambling disorder is the only behavioral addiction listed alongside substance use disorders in the DSM-5, the diagnostic manual clinicians use. A clinician diagnoses it when a person shows at least four of nine specific criteria within a 12-month period, such as repeatedly chasing losses, lying to conceal gambling, or relying on other people to cover gambling debts. In California, free and confidential help for gambling problems is available around the clock by calling 1-800-GAMBLER, and the condition can be assessed and addressed during residential treatment for alcohol or drug use.

The nine criteria cover needing to gamble with larger amounts to get the same excitement, restlessness or irritability when trying to cut back, repeated unsuccessful attempts to stop, frequent preoccupation with gambling, gambling when distressed, returning to win back losses, lying about the extent of gambling, putting a relationship, job, or educational opportunity at risk, and relying on others for money to relieve a desperate financial situation. The diagnosis is made by a clinician in an assessment, not by a checklist at home. What matters for treatment planning is that the clinical team knows to ask.

Why Gambling and Substance Use So Often Show Up Together

Research bodies such as the National Institute of Mental Health describe co-occurring conditions as common rather than exceptional, and that pattern holds for gambling. Clinicians generally point to several overlapping drivers:

  • Shared reward pathways: Both gambling and substance use act on the brain’s reward and motivation systems, so a person primed by one can be more responsive to the other.
  • Lowered inhibition: Alcohol and stimulants make larger, faster, riskier bets more likely, and many people describe their worst losses happening while intoxicated.
  • Chasing in both directions: Losses create stress, stress drives use, and use drives more gambling to “fix” the losses.
  • Money as a trigger: A paycheck, a refund, or a cash gift can trigger both cravings at once, which is why money handling becomes part of the recovery plan.
  • Substitution in early recovery: When drinking or drug use stops, some people find gambling fills the same space, which is why clinicians watch for it after a substance is removed.

What We See in Practice During the First Week

Writing from years of admissions and case management work, the pattern I see most often is not a person who arrives saying “I have a gambling problem.” It is a person who arrives in a financial emergency they have not fully explained. Week one is when the phone calls from creditors start, when a spouse discovers a second credit card, or when someone asks staff whether they can “just check one account.” The gambling was often hidden even from the person’s own sense of the problem, because the alcohol or drug use seemed like the bigger issue.

An inconvenient operational truth: many standard substance use intake forms ask little or nothing about gambling. Some programs use a brief gambling screen at assessment and some do not. If you do not raise it, it can go unaddressed for an entire stay. Families also tend to notice it first. They see missing money, new loans, sports betting apps, online casino or sweepstakes-style sites, or a person who is unusually tense around game schedules.

How Residential Treatment Addresses Both

A good residential program treats gambling as part of the same clinical picture rather than a side issue. The level of care itself is set by the substance use and medical needs, using frameworks such as the ASAM Criteria. Within that stay, gambling can be addressed through:

  • A clinical assessment that asks directly about betting, debts, and how gambling and use interact.
  • Cognitive behavioral approaches that target the thinking errors common in gambling, such as the belief that a win is “due.”
  • Relapse prevention planning that treats payday, sports seasons, and idle phone time as specific risk points.
  • Family sessions that address trust, financial transparency, and who holds which accounts after discharge.
  • Discharge referrals to gambling-specific outpatient care and peer support, alongside substance use aftercare.

Withdrawal still comes first. If the person is drinking heavily or taking benzodiazepines daily, stopping can cause seizures, and withdrawal from either must be medically supervised. No one should stop alcohol or benzodiazepines abruptly on their own to “get ready” for treatment. You can learn more about how our residential treatment program sequences detox, stabilization, and therapy.

What to Tell Admissions Before You Arrive

Here is something you can do today. Before your admissions call, write down three things on one sheet of paper:

  1. A rough total of gambling-related debt: include credit cards, payday or online loans, and money borrowed from family or friends. An estimate is fine.
  2. Any payment due dates in the next 30 days: so the team can help you plan for them instead of being blindsided mid-stay.
  3. Who currently has access to your accounts and cards: and who you would trust to hold them while you are in treatment.

Then say plainly on the call: “I also have a problem with gambling,” and ask, “How does your program assess and treat gambling alongside substance use?” Listen for a specific answer, such as a named screening tool, a clinician who works with gambling, or a family session on finances. A vague answer is useful information too. You can reach our admissions team at (877) 328-1968, and it helps to verify your insurance ahead of the call so the conversation can focus on care.

Practical Money Safeguards for the First Weeks

These steps are commonly recommended and can be set up before or during a stay, ideally with a trusted family member:

  • Ask your bank or card issuer whether it offers a gambling transaction block. Many do, and it can often be turned on in an app or by phone.
  • Give a trusted person temporary control of cards and access to account statements.
  • Delete betting and casino apps, and consider device-level blocking software.
  • Pause any automatic transfers into betting or casino accounts.
  • Avoid taking on new loans or consolidating debt in the first weeks; financial decisions are easier once you are stable.

For families, the goal is protection, not punishment. Holding the money for a while is a recovery support, and it works best when the person in treatment agrees to it.

Safety: When Losses Become a Crisis

Large gambling losses, especially combined with alcohol or drug use, can bring on intense shame and hopelessness. If you or someone you love is thinking about suicide or is in emotional crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline. For confidential treatment referral information about substance use, the SAMHSA National Helpline is free and available 24 hours a day. For gambling specifically in California, call 1-800-GAMBLER.

Getting Help in Northern California

Bodhi Addiction Treatment & Wellness provides residential drug and alcohol treatment in Northern California, with assessment that looks at the whole picture, including gambling, mood, and family stress. If money problems and substance use are tangled together for you or someone you love, you do not need to sort out which came first before calling. Call (877) 328-1968 to talk through the next step.

Written by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i, founder of Bodhi Addiction Treatment & Wellness.

This article is for educational purposes only and is not a substitute for professional medical, psychological, legal, or financial advice. Diagnosis of gambling disorder or a substance use disorder should be made by a qualified clinician. Never stop alcohol or benzodiazepines suddenly without medical supervision. If you are in immediate danger, call 911.

/by

From the Hospital or ER to Residential Treatment: Medical Clearance, the Discharge Summary, and What to Tell Admissions

, ,
Partial Hospitalization — Bodhi Addiction Treatment & Wellness

A trip to the emergency room is often the moment a family finally says the word “treatment” out loud. Someone has a withdrawal seizure, an overdose is reversed, a fall leads to a blood alcohol reading nobody can explain away. The ER doctor says the person needs residential care. Then the discharge paperwork arrives, and nobody in the room knows what happens next.

This post walks through the handoff from a hospital or emergency department to residential treatment: what “medical clearance” means, what the discharge summary needs to contain, how the timing works, and what to tell admissions when you call. It is written from the admissions and case management side, where most transfers that fall apart do so over paperwork and timing, not willingness.

The Short Version: What a Hospital-to-Residential Transfer Requires

A transfer from a hospital or emergency department to residential addiction treatment usually depends on three things being in place before the person leaves the hospital: a medical clearance stating they are stable enough for a non-hospital setting, a discharge summary listing every medication with the time of the last dose, and a confirmed bed with a stated arrival time. Alcohol withdrawal symptoms commonly begin within 6 to 24 hours of the last drink, so if any of those three pieces is missing when someone is discharged, the gap between the hospital door and the residential intake can fall exactly when withdrawal is starting. Calling the residential program from the hospital, before discharge, is the single step that closes that gap most often.

What “Medical Clearance” Actually Means

Medical clearance is a clinician’s statement that the person’s acute medical problem has been treated and they no longer need hospital-level care. It does not mean they are healthy, and it does not mean withdrawal is over. It means the next level of care can safely take over.

Residential programs are organized around the ASAM Criteria, the American Society of Addiction Medicine’s framework for matching people to levels of care. The fourth edition, published in 2023, describes residential care in tiers, including clinically managed residential care (Level 3.5) and medically managed residential care (Level 3.7). Whether a program can accept someone straight from the ER depends on which tier it provides and what the person still needs medically.

The reasons a residential program may ask for more information before accepting a hospital transfer usually fall into a few categories:

  • Unresolved withdrawal risk: Someone still in early alcohol or benzodiazepine withdrawal may need medically supervised withdrawal management first, because both can cause seizures.
  • Unstable vital signs or lab values: Abnormal heart rate, blood pressure, electrolytes or liver values may need to settle before a non-hospital setting is appropriate.
  • Active psychiatric crisis: Current suicidal intent or psychosis generally needs psychiatric stabilization before residential addiction care.
  • Wounds, infections or new prescriptions: Antibiotic courses, wound care or new medications need clear written orders the residential medical team can continue.

The Discharge Summary: What It Needs to Say

In my work coordinating admissions and intervention cases, the most common reason a same-day hospital transfer stalls is not the person’s readiness. It is a discharge summary that arrives late, incomplete, or not at all. The residential medical team cannot safely continue care they cannot see.

Ask the hospital team to make sure the discharge paperwork includes:

  • Every medication given in the hospital, including anything for withdrawal, with the dose and the exact time of the last dose. “Received lorazepam” is not enough; “lorazepam 2 mg at 03:40” is.
  • Discharge prescriptions, and whether they were filled. Residential programs generally need medications in hand or a plan to obtain them on arrival.
  • Lab results and any pending results, such as liver function, electrolytes or toxicology.
  • The diagnosis and reason for the visit, including any seizure, overdose or injury.
  • Follow-up instructions, such as a wound check, a repeat lab or a specialist appointment.

Because of federal privacy rules covering substance use treatment records, the hospital and residential program usually need the patient’s signed consent to share information with each other. Signing that release at the hospital, naming the residential program, saves hours.

Why Timing Matters So Much

The risk in a hospital-to-residential transfer is concentrated in the window between discharge and intake. A person discharged at 2 a.m. with instructions to “call a treatment center in the morning” may spend those hours alone, starting to withdraw, with access to alcohol or drugs and the strongest reason they will ever have to use them.

Alcohol and benzodiazepine withdrawal can cause seizures and, in severe cases, delirium. Withdrawal from either substance requires medical supervision; it should never be managed alone at home. According to the National Institute on Alcohol Abuse and Alcoholism, heavy drinking affects nearly every organ system, which is part of why withdrawal is treated as a medical event rather than a test of willpower.

Opioid use creates a different timing risk. After a period without opioids, including a hospital stay, tolerance drops. A return to the previous amount, particularly with fentanyl in the supply, can be fatal. Ask the hospital whether the person can leave with naloxone and whether starting buprenorphine before discharge is an option. Both are questions to raise before the paperwork is signed, not after.

What to Do Today if Someone Is in the Hospital Now

If someone you love is in an emergency department or hospital bed right now, these steps can be done today, in this order:

  1. Ask the nurse when discharge is expected. Get a time, even an estimate. This tells you how long you have.
  2. Call residential admissions from the hospital. Bodhi’s admissions team can be reached at (877) 328-1968. Have the person’s insurance card, date of birth and a list of what they have been using ready.
  3. Ask the hospital social worker or case manager to speak directly with admissions. A clinician-to-clinician call answers medical questions faster than relaying them through family.
  4. Have the patient sign a release allowing the hospital to send records to the residential program.
  5. Confirm transport. Who is driving, and when? A person in early withdrawal should not drive themselves.
  6. Do not let discharge happen into an empty gap. If no bed is confirmed, ask the hospital team directly: “Can discharge wait until a residential bed is confirmed, or is there a withdrawal management option tonight?”

What to Tell Admissions When You Call

Admissions teams are trying to answer one question: can this program safely meet this person’s needs starting today? You can help by having these answers ready:

  • Why the person went to the hospital, and what happened there.
  • What they have been using, roughly how much, and when they last used. Exact answers matter more than polite ones.
  • Any history of withdrawal seizures, delirium or prior detox.
  • Every medication they take, including anything started in the hospital.
  • Any mental health diagnoses, recent suicidal thoughts, or psychiatric holds.
  • Insurance details. You can also start the process through our insurance verification page.

It is normal for admissions to repeat the ER’s questions; each setting makes its own safety decision. If the answer is that the person needs a higher level of care first, a good admissions team will tell you that plainly and help you find it rather than accepting someone they cannot safely treat.

After Arrival: What the First Day Looks Like

On arrival, the residential medical team typically reviews the hospital records, checks vital signs, reconciles medications, and assesses withdrawal risk again. That repeat assessment is not distrust of the hospital; withdrawal changes hour by hour, and the person who left the ER is not quite the same person who arrives. Our residential treatment program page describes what the first days of care involve in Northern California.

For families, the first few days are often quiet. Phone contact may be limited while the person stabilizes, and staff can only share information the patient has consented to share. Asking at intake, “Who is listed on the release, and when will the first family call happen?” gives you a concrete answer instead of a long wait.

When to Call 911 or 988 Instead

If someone has a seizure, becomes confused or hard to wake, has trouble breathing, or shows signs of overdose, call 911. If someone is in emotional crisis or talking about suicide, call or text 988, the Suicide & Crisis Lifeline. For confidential treatment referral information at any hour, the SAMHSA National Helpline is available 24 hours a day, 365 days a year.

If the hospital stay has opened a door, the next step is a phone call while the person is still under medical care. Our admissions team can talk through options and timing at (877) 328-1968.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Alcohol and benzodiazepine withdrawal can be life-threatening and require medical supervision. If you or someone you know is in immediate danger, call 911. For a mental health crisis, call or text 988.

/by

Benzodiazepine Dependence and Residential Treatment: Why Tapers Are Slow, the Seizure Risk, and What to Tell Admissions

, ,
Prescription bottle with pills on a counter — residential rehab for chronic pain and opioid use disorder

Benzodiazepines such as alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and diazepam (Valium) are some of the most commonly prescribed medications in the country, and many people who end up needing residential treatment started taking them exactly as a doctor directed. That is part of what makes the admissions process for benzodiazepine dependence different from almost any other substance. This guide explains how residential programs approach it, why the timeline is slower than people expect, and the specific information admissions will ask you for.

The Short Answer: Benzodiazepine Withdrawal Is Never Done Cold Turkey

Stopping a benzodiazepine abruptly after regular use can cause seizures, severe rebound anxiety, confusion, and in some cases delirium. In September 2020 the U.S. Food and Drug Administration required the boxed warning on every benzodiazepine to be updated to address abuse, misuse, addiction, physical dependence, and withdrawal reactions, and that warning states that abrupt discontinuation or rapid dose reduction can cause serious, potentially life-threatening withdrawal. For that reason, anyone who has been taking a benzodiazepine daily for more than a few weeks should only reduce or stop it under medical supervision, usually with a gradual taper that is planned before admission rather than improvised after it.

If you are worried about yourself or someone else right now, call (877) 328-1968 to talk through options, or call 911 if someone is having a seizure, is unresponsive, or is confused and agitated after stopping a medication.

Why Benzodiazepine Withdrawal Is Medically Different

Most people know that opioid withdrawal is miserable. Fewer people know that benzodiazepine and alcohol withdrawal are the two that can be dangerous on their own. The reasons are worth understanding because they shape every decision admissions makes.

  • GABA adaptation: Benzodiazepines enhance the brain’s main calming signal, so with daily use the brain turns its own calming system down, and removing the drug suddenly leaves the nervous system overexcited.
  • Seizure threshold: That overexcited state lowers the seizure threshold, which is why both benzodiazepine and alcohol withdrawal carry seizure risk and require medical supervision.
  • Half-life differences: Short-acting drugs such as alprazolam can produce withdrawal within a day or two of the last dose, while long-acting drugs such as diazepam may not show withdrawal for several days, which can create false reassurance.
  • Combination risk: Benzodiazepines combined with alcohol or opioids increase the risk of slowed breathing and overdose, a combination the National Institute on Drug Abuse specifically warns about.
  • Counterfeit pills: Pills bought outside a pharmacy that look like alprazolam may contain other sedatives or fentanyl, so the actual dose a person has been taking is often unknown.

What Week One Actually Looks Like

People are often surprised that the first week of residential care for benzodiazepine dependence can feel quieter than they feared. When a taper is managed well, the medical team usually stabilizes the person on a known dose first, often converting to a longer-acting benzodiazepine so blood levels stay steadier, and then begins reducing slowly. The common complaints in the first days are poor sleep, a jittery or “wired” feeling, irritability, and heightened sensitivity to light and sound. Families often notice that their loved one is more anxious than before admission, and they worry that treatment is making things worse. In most cases this is the expected rebound, not a sign that the plan has failed, and it is something the clinical team is watching for.

What a residential setting adds is that the person is not managing those symptoms alone at home with a pill bottle in the cabinet. Group therapy, structured sleep routines, and skills for managing anxiety without medication begin while the taper is still underway, so that by the time the dose reaches zero, the person has already practiced coping tools.

Why the Taper Often Takes Longer Than the Stay

Here is the inconvenient operational truth that families are rarely told up front: for someone who has taken a benzodiazepine daily for months or years, a medically sensible taper can last longer than a typical residential stay. Current guidance from the American Society of Addiction Medicine and partner organizations favors gradual, individualized reductions over rapid detox, and the pace is adjusted to how the person responds. That means the residential program often begins the taper, gets the person stable and engaged in recovery work, and then hands the rest of the taper to an outpatient prescriber with a written plan.

From the referral side, the most common breakdown we see is not in the residential phase. It is the handoff. A person leaves residential care partway through a taper without a confirmed appointment, runs out of medication, and either stops abruptly or returns to a non-pharmacy supply. Before discharge, ask the program to name the outpatient prescriber who will continue the taper and confirm the first appointment date in writing. Our outpatient treatment options are built to continue that kind of plan.

What to Tell Admissions: A Checklist You Can Complete Today

Admissions teams need accurate information to decide whether a person needs a medically monitored detox first or can taper safely inside a residential treatment program. Before you call, write down the following. It takes about fifteen minutes and it is the single most useful thing you can do to speed up placement.

  1. Every benzodiazepine, by name: Include ones taken “only as needed” and sleep medications such as zolpidem (Ambien), which act on the same system.
  2. Actual daily amount: What is really being taken, not what the label says. If the amount varies, give the highest recent day.
  3. Time of the last dose: This tells the medical team where the person is on the withdrawal timeline.
  4. Source: Pharmacy, a friend’s prescription, or pills bought online or on the street. Non-pharmacy pills change the risk assessment because of counterfeit content.
  5. Alcohol and opioid use: Any combination changes the level of medical monitoring required.
  6. Seizure history: Any past seizure, including during a previous attempt to stop.
  7. The prescriber’s name and phone number: The program will want to coordinate, with your written consent.

In California, prescribers and pharmacists can check the state prescription drug monitoring database, known as CURES, to see controlled-medication fills. You can also ask your own pharmacy for a printout of your fill history before you call. Bringing that printout to the admissions conversation removes guesswork about doses and dates.

Questions to Ask Before You Choose a Program

Not every residential program is set up to manage benzodiazepine withdrawal on site. Ask these questions directly:

  • Do you have 24-hour nursing and a prescriber who can manage a benzodiazepine taper, or will I need a separate detox first?
  • How do you decide the starting dose and the pace of reduction?
  • What happens if withdrawal symptoms become severe at night?
  • How will the taper continue after discharge, and who will prescribe it?
  • Will my insurance treat detox and residential care as one authorization or two? (Our team can help you verify insurance benefits before admission.)

The SAMHSA National Helpline is another free, confidential resource for finding treatment, available 24 hours a day.

A Note for Families

If your loved one takes a benzodiazepine every day, please do not hide, flush, or ration their medication to force the issue. Taking the supply away abruptly can trigger the same dangerous withdrawal described above. The safer path is to encourage a conversation with their prescriber or with an admissions team, and to help gather the information on the checklist. Many people who depend on benzodiazepines feel deep shame because they “only did what the doctor said.” Leading with that understanding, rather than with accusation, tends to make the first call easier.

Getting Help in Northern California

Bodhi Addiction Treatment & Wellness helps individuals and families in Santa Cruz County and across Northern California find the right level of care, including medically supervised withdrawal and residential treatment. If you or someone you love is ready to talk about a safe plan for stopping benzodiazepines, call (877) 328-1968. If you are in emotional crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Do not stop, reduce, or change any medication, including a benzodiazepine, without guidance from a qualified healthcare provider. Benzodiazepine and alcohol withdrawal can cause seizures and require medical supervision. If you are experiencing a medical emergency, call 911.

/by

Older Adults and Residential Treatment: The Medication Check, Withdrawal Safety, Medicare Questions, and What to Tell Admissions

, , ,
Outpatient Rehab Near Santa Cruz

Families usually call about an older parent after something specific happens: a fall in the kitchen, a fender-bender, a hospital discharge that mentioned “alcohol use” in the notes, or a pharmacist who flagged a refill pattern. By the time a person in their late sixties or seventies is being considered for residential treatment, the question is rarely whether there is a problem. The question is how to admit someone safely when they are also managing blood pressure, sleep, pain, mood, and often a long list of prescriptions.

This guide explains what admissions needs to know for an older adult, why the medication list matters more than almost anything else, and what you can do today to make the first week safer.

The Number That Shapes Every Older-Adult Admission

According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), about 80% of people aged 65 and older took a medication in the past year that could interact with alcohol. For an older adult entering residential treatment for alcohol or drug use, that makes a full medication reconciliation, covering prescriptions, over-the-counter products, and supplements, the first safety task of admission rather than paperwork to finish later. Interactions between alcohol and sedating medications can raise the risk of falls, memory problems, and overdose, so the admitting medical team needs the complete list before the first dose is given.

That figure comes from NIAAA’s clinician resource on alcohol-medication interactions, which also notes that the size of this age group, and the share taking alcohol-interactive medications, is growing.

Why Older Adults Need a Different Admission Plan

Substance use in later life is not a smaller version of substance use at 35. The body processes alcohol and medications differently, and the consequences of a mistake are larger. NIAAA’s overview of aging and alcohol describes several of these changes. In practical terms for admissions, they look like this:

  • Less body water and muscle: The same number of drinks can produce a higher blood alcohol concentration than it did decades ago, so “I only have two glasses of wine” may mean more than it sounds.
  • More prescriptions in play: Medications for anxiety, sleep, pain, blood pressure, and infections can all interact with alcohol, and each new prescriber may not know about the others.
  • Sedative overlap: Alcohol combined with benzodiazepines, sleep aids, or opioid pain medications adds sedation and can slow breathing, which is why the order and timing of medications in the first days matter.
  • Fall and injury risk: Older adults are more sensitive to alcohol’s effects on balance and coordination, so a bathroom trip at 3 a.m. during early withdrawal is a real clinical concern, not a minor one.
  • Symptoms that look like something else: Confusion, poor sleep, low appetite, and memory lapses can be read as “normal aging” or early dementia when they are partly driven by alcohol or medication effects.

Withdrawal Safety: Why This Cannot Be Done at Home

Alcohol and benzodiazepine withdrawal can cause seizures and, in severe cases, delirium. Both require medical supervision. This is true at any age, but older adults often have heart, liver, or kidney conditions that make withdrawal harder to manage and medication dosing more delicate.

Please do not have an older family member stop drinking or stop a benzodiazepine abruptly before admission to “get a head start.” A sudden stop can trigger withdrawal at home, without monitoring. Keep the current pattern steady, tell admissions exactly what it is, and let the medical team plan the transition. If someone shows confusion, hallucinations, a seizure, or a fast heart rate with shaking and sweating, call 911.

Programs that offer residential treatment with medical oversight can monitor withdrawal around the clock, adjust medications as symptoms change, and watch for problems that are easy to miss in an older patient, such as dehydration or a change in mental status.

What to Do Today: The Brown-Bag Medication Check

This is the single most useful thing a family can do before an older adult’s admission call. It takes about 20 minutes.

  1. Gather every bottle. Put every prescription, over-the-counter product, vitamin, supplement, cough syrup, and sleep aid into one bag. Include items in the bathroom, the bedside table, the car, and the purse.
  2. Photograph each label. Capture the drug name, dose, prescriber, pharmacy, and fill date. Admissions can work from photos if bottles are not brought on the first call.
  3. Write down how each one is actually taken. Not how it is prescribed, but how it is used. “Lorazepam 0.5 mg, prescribed as needed, taking two most nights” is the kind of detail that changes a withdrawal plan.
  4. Write the drinking pattern plainly. Typical drinks per day, what kind, the time of the last drink, and whether there has ever been shaking, seizures, or confusion when stopping.
  5. List every prescriber. Older adults often have a primary care doctor, a cardiologist, a pain specialist, and a psychiatrist who do not share notes.

Bring that bag and that page to the admissions call. If you are not sure where to start, our admissions team can walk through it with you at (877) 328-1968.

Questions to Ask Admissions for an Older Adult

These are procedural questions. A program that serves older adults well should be able to answer each one directly.

  • Who reviews the full medication list, and when? Is it a physician or a nurse practitioner, and does it happen before the first dose?
  • How is withdrawal monitored overnight, and how often is the person checked?
  • What fall precautions are in place: bed height, night lighting, bathroom access, and staff response?
  • Can the program manage existing conditions such as diabetes, heart disease, or COPD, and which conditions would require a hospital-based setting instead?
  • How are cognitive concerns screened, and how is memory or confusion separated from withdrawal effects?
  • How will the program coordinate with the person’s current prescribers at discharge?

Insurance and Medicare: Check Before You Assume

Families are often surprised by how coverage works for older adults. Medicare benefits for residential substance use treatment are narrower than many people expect, and what is covered depends on the setting, the specific plan, and whether the person has Original Medicare, a Medicare Advantage plan, or retiree coverage through a former employer. Some people have more than one source of coverage. Rather than guessing, ask for a written benefits check before admission. You can start that process through our insurance verification page, and ask specifically which levels of care are covered, whether prior authorization is required, and what out-of-pocket costs to expect.

What We See in Admissions

From the admissions side, the most common gap with callers over 65 is not reluctance about treatment. It is an incomplete medication picture. The family knows about the wine. They often do not know about the sleep aid from one doctor, the anxiety prescription from another, and the over-the-counter allergy pill taken nightly for sleep. Each piece looks minor on its own. Together they change how the first 72 hours need to be managed.

The second pattern is shame. Older adults frequently grew up when drinking problems were not discussed, and many have managed a career and a family while drinking. Treatment works better when the conversation is framed around safety and health, such as “your doctor is worried about the falls and the medications,” rather than around labels. Person-first, practical language keeps the door open.

Recovery in later life is realistic. Older adults often bring patience, life experience, and clear reasons to change, such as grandchildren, independence, and staying in their own home. Outcomes vary from person to person, and no program can promise a result, but a careful medical start gives treatment its best chance.

Getting Started

If you are weighing residential care for a parent or older loved one, gather the medication bag, write down the drinking pattern, and call. You can reach Bodhi Addiction Treatment and Wellness at (877) 328-1968 to talk through medical needs, coverage, and timing. For free, confidential treatment referral information at any hour, SAMHSA operates a national helpline. If you or someone you love is in crisis, call or text 988, or call 911 in a medical emergency.

This article was written by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i. It is for educational purposes only and is not medical advice. It does not replace an assessment by a physician or qualified clinician. Never stop alcohol, benzodiazepines, or any prescribed medication abruptly without medical supervision, as withdrawal can be dangerous.

/by

Xylazine (Tranq) and Residential Treatment: Wound Care, Withdrawal Planning, Naloxone, and What to Tell Admissions

,
IV drip on a stainless steel stand — 5-day medical detox in residential rehab

Xylazine rarely comes up by name on an admissions call. People describe “fentanyl that hits different,” a sedation that lasts longer than the high, or a sore on the shin that will not close. Families describe someone who nods off for hours and is hard to wake. Those details matter, because xylazine changes how overdose is handled, how withdrawal is planned, and whether a residential program is set up to care for the wounds it causes. This post explains what xylazine is, what it means for admission to residential treatment, and exactly what to tell the admissions team before you arrive.

What Xylazine Is, in One Paragraph

Xylazine, a veterinary sedative sold on the street as “tranq,” is not an opioid and is not reversed by naloxone. It is not approved for use in people, yet the DEA’s laboratory system reported that about 23% of the fentanyl powder and 7% of the fentanyl pills it seized in 2022 contained xylazine, according to the Centers for Disease Control and Prevention (CDC). Because xylazine almost always arrives mixed with fentanyl, the CDC still advises giving naloxone in any suspected overdose, calling 911, and giving rescue breaths, since xylazine’s sedation can continue after naloxone has worked on the opioid.

The National Institute on Drug Abuse (NIDA) notes that many people take xylazine without knowing it is in their supply. NIDA also reports that, across 20 states and the District of Columbia, the share of fentanyl-related overdose deaths with xylazine detected rose from 2.9% in January 2019 to 10.9% in June 2022. Rates vary by region, and the supply changes quickly, so a person in Northern California may have been exposed without ever seeking it out.

Why Xylazine Changes the Admission Plan

From the admissions side, xylazine exposure is less about a new diagnosis and more about four practical problems that have to be planned for before day one:

  • Overdose that naloxone only partly reverses: naloxone reverses the fentanyl, but xylazine can keep breathing, heart rate, and blood pressure dangerously low, so staff and family need to know rescue breathing and 911 still come next.
  • Wounds that appear away from injection sites: NIDA reports that xylazine-related sores often show up elsewhere on the body, and some clinicians report them in people who smoke or snort rather than inject.
  • Withdrawal that may be harder than fentanyl alone: early research cited by NIDA suggests withdrawal symptoms may be more intense with xylazine plus fentanyl, and no medical association has yet published a xylazine-specific withdrawal guideline.
  • A drug screen that will not show it: standard urine drug panels do not test for xylazine, so the clinical team often learns about exposure only from what the person or family reports.

That last point is the inconvenient operational truth. If nobody mentions xylazine or a wound during the pre-admission screening, the team may plan an ordinary opioid admission and only discover the wound during the physical exam on arrival. Some wounds can be managed in a residential setting with daily dressing changes and a medical provider’s oversight. Others need hospital or wound-clinic care first. The admissions team can only make that call in advance if they are told.

Wound Care: What Residential Programs Can and Cannot Do

According to NIDA, xylazine-related wounds range from skin infections and abscesses to open, weeping ulcers, and untreated wounds can progress to dead tissue and, in rare severe cases, amputation. NIDA notes that medical associations have not issued formal treatment guidelines, but early evidence favors keeping wounds clean and open rather than closed with stitches or grafts. Wounds can heal while a person is still using, though early data suggest healing is slower with continued xylazine exposure.

In practice, this is what to expect from a residential program that accepts someone with a xylazine-related wound:

  • A physical exam on arrival that documents each wound, its size, and any signs of infection.
  • A dressing plan, with who changes dressings and how often written down.
  • A pain plan, because these wounds hurt, and untreated pain is a common reason people leave early.
  • A clear threshold for sending the person out: fever, spreading redness, a foul smell, or a wound that is getting deeper means same-day medical evaluation, not waiting for the next scheduled visit.

If a program cannot describe that plan, ask whether medical clearance from a primary care provider, urgent care, or wound clinic is needed first. Asking that question on the phone is far better than discovering the gap at intake.

Withdrawal Planning When Xylazine Is Involved

Most people exposed to xylazine are also dependent on fentanyl, so withdrawal planning starts with opioid withdrawal management and a discussion of medications for opioid use disorder, which the Substance Abuse and Mental Health Services Administration (SAMHSA) identifies as an evidence-based part of treatment. Xylazine adds uncertainty: symptoms such as anxiety, restlessness, and irritability may be stronger or last longer, and there is currently no medication approved specifically for xylazine withdrawal, so clinicians treat the symptoms they see.

Safety note: NIDA reports that most overdose deaths involving both xylazine and fentanyl also involved other substances, including benzodiazepines and alcohol. Withdrawal from alcohol or benzodiazepines can cause seizures and can be life-threatening. If either is part of the picture, withdrawal must happen under medical supervision, and nobody should stop alcohol or benzodiazepines abruptly on their own while waiting for a bed.

This is one reason a residential treatment admission for someone with xylazine exposure usually begins with a medically monitored stabilization period rather than going straight into a full group schedule.

What to Tell Admissions: A Checklist You Can Use Today

Before the screening call, write down the answers to these questions. If you are a family member, ask your loved one for permission to share them, or have them on the call with you.

  1. What is being used, and how? List every substance, including alcohol, benzodiazepines, gabapentin, and stimulants, and whether each is injected, smoked, snorted, or swallowed.
  2. When was the last use of each? Give a date and approximate time. This sets the withdrawal timeline.
  3. Has anyone said “tranq” or noticed unusually long sedation? Mention it even if you are not sure.
  4. Are there any wounds? Note how many, where on the body, roughly how large, and whether any are red, hot, draining, or smell bad. A photo taken today can help the medical team decide whether clearance is needed first.
  5. Any recent overdoses? Say whether naloxone was used and whether it fully worked.
  6. Current prescriptions and pharmacy. Include any buprenorphine or methadone dose.

Then ask the admissions team two direct questions: “Can your medical staff manage open wounds on site, and how often are dressings changed?” and “Do you need medical clearance before admission for someone with these wounds?” You can reach our admissions team at (877) 328-1968, and it helps to verify insurance in the same call so the clinical and financial questions are settled together.

While You Wait for a Bed

The days between the first call and admission carry real risk. Keep naloxone in the home and make sure more than one person knows where it is. If someone is unresponsive or breathing slowly, give naloxone, call 911, and give rescue breaths if you are able, then stay with them; the CDC notes that xylazine’s effects can continue after naloxone. Xylazine test strips are commercially available and offered by some harm reduction programs, according to NIDA. Keep any wound clean and covered, and get it seen the same day if it shows signs of infection.

A Note From Clinical Practice

This guidance reflects the admissions and case management work of Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i. The pattern that most often delays care is not the xylazine itself but the missing detail: a wound nobody mentioned, or a benzodiazepine nobody listed. Admissions teams are not looking for reasons to turn people away. They are trying to make sure the first 72 hours are medically safe. The more specific the information on the first call, the faster that plan comes together. If you are unsure whether a program is the right fit, call (877) 328-1968 and ask the questions above.

This article is for educational purposes only and is not medical advice. It does not replace an evaluation by a licensed medical provider. If someone is unresponsive, not breathing, or breathing very slowly, call 911 immediately. If you or someone you know is in emotional crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline.

/by

Family Contact During Residential Treatment: 42 CFR Part 2 Consent, Phone and Visiting Policies, and What to Ask Admissions

, , ,
People sitting at a table in a calm indoor conversation — talking to a loved one about rehab

One of the first things families ask after a loved one is admitted to residential treatment is simple: When can I call, and will anyone tell me how they are doing? The answer is shaped less by the treatment program’s preferences than by a federal confidentiality rule that most families have never heard of. Knowing how it works before admission day saves a lot of frustrated phone calls.

The Rule That Governs Family Updates: 42 CFR Part 2

Under the federal confidentiality regulation 42 CFR Part 2, a federally assisted substance use disorder treatment program generally cannot disclose any information that identifies a person as a patient, including simply confirming that they are admitted, without that person’s written consent. This applies to spouses, parents and adult children, and it is stricter than the general HIPAA rules most people know from hospital visits. HHS updated Part 2 in a 2024 final rule that aligned parts of it more closely with HIPAA, with a compliance date of February 16, 2026, but the core requirement of written patient consent before telling family members anything remains in place. Programs that follow it are not being evasive; they are following federal law. SAMHSA’s confidentiality guidance explains the rule in plain language.

The inconvenient operational result: if a parent calls the front desk on day two and no consent form is on file, the honest answer staff can give is that they cannot confirm or deny whether that person is a patient. Families often hear this as a brush-off. It is the law working as designed, and it is fixed with one form signed at admission.

What the Consent Form Has to Contain

A valid Part 2 consent is more specific than a general release. Expect the form to list:

  • The named recipient: the specific person or people who may receive information, such as “Maria Lopez, mother.”
  • The purpose: why the information is being shared, for example to coordinate family support and discharge planning.
  • The scope of information: how much and what kind, which can be as narrow as “attendance and general progress” or as broad as clinical updates.
  • An expiration: a date, event or condition when the consent ends.
  • The right to revoke: a statement that the patient can withdraw consent at any time, except for information already shared in reliance on it.

Because the person in treatment controls the scope, they can authorize their partner to hear general progress without authorizing details of individual therapy. That flexibility often makes people more willing to sign.

Why Phone and Visiting Access Is Often Limited at First

Many residential programs restrict phone use and visits during the first days or week of a stay. Policies differ, so the specific length is a question for admissions, not something to assume. The reasons are practical rather than punitive:

  • Medical stabilization: the first days may overlap with withdrawal, and alcohol or benzodiazepine withdrawal can cause seizures and must be medically supervised, so staff need the person focused and observable.
  • Early-stay ambivalence: a person who is uncomfortable in week one may call home asking to be picked up, and a short settling period gives the urge to leave time to pass.
  • Outside contacts: unrestricted phones can reconnect someone with people they used with or bought from, which is one of the more common ways early treatment is derailed.
  • Routine building: group therapy, meals and sleep run on a schedule, and the structure is part of the treatment.

What families usually observe is that the first scheduled call sounds flat or irritable, and calls in the second and third week sound noticeably steadier. That pattern is common and is not, on its own, a sign that treatment is failing.

Five Questions to Ask Admissions Before Day One

You can do this today. Before admission, call the program and ask these questions, then write down the answers:

  1. Who signs the Part 2 consent, and when? Ask whether it can be signed during intake so the named family contact is on file before the first evening.
  2. Who is my single point of contact? Most programs route family updates through one clinician or case manager rather than whoever answers the phone.
  3. What is the phone policy and the first-call timeline? Ask how long any initial restriction lasts and whether calls are scheduled or open.
  4. When and how do visits happen? Ask about visiting days, whether children may attend, and whether visits are supervised.
  5. Is there structured family programming? Ask whether family sessions or education groups are offered, and whether they are in person, virtual or both.

If you are helping someone prepare for admission and want these answered in one conversation, our admissions team can walk you through them at (877) 328-1968.

Why Family Involvement Is Worth the Paperwork

The National Institute on Drug Abuse’s principles of effective treatment describe addiction treatment as addressing the whole person, including family and social circumstances, not only substance use. In practice, the family is usually where the person returns after discharge, so the people at home benefit from understanding the discharge plan, any medications, warning signs and what support looks like in the first weeks.

Family involvement is not the same as family control. Good programs help relatives learn what they can and cannot influence, how to set boundaries without ultimatums, and how to look after their own health. If a family member’s own wellbeing is suffering, SAMHSA’s National Helpline offers free, confidential referral information.

What to Do If Your Loved One Won’t Sign Consent

Some people decline to sign at intake, especially in the first, hardest days. A few things are still possible:

  • Staff can still listen: the rule restricts what the program discloses, not what you share. You can call and provide history, medication information or concerns, and staff can take that information without confirming anything back.
  • Consent can come later: many people sign once they have settled in. Ask the clinician to revisit it after the first week.
  • Emergencies are handled differently: Part 2 allows disclosure to medical personnel in a bona fide medical emergency. It does not allow routine updates to family.

If you believe someone is in immediate danger, call 911. For a mental health or suicidal crisis, call or text 988.

Preparing for the First Call Home

When the first call comes, keep it short and steady. Tell them you are glad to hear from them, avoid relitigating the events that led to admission, and do not negotiate an early pickup on the phone. If they ask to leave, say you will talk with their clinician, then do so. Leaving early is a clinical decision with real risks, and the treatment team can help you think it through.

Families in Northern California considering residential treatment can also start by verifying insurance coverage before the admission date, which removes one more unknown from the first week. If you are still deciding whether residential care is the right level, a free consultation can help you compare options and understand what a typical week looks like for both the person in treatment and the family at home. Questions about visiting, consent or family programming can go to our team at (877) 328-1968.

This article is for educational purposes only and is not medical or legal advice. Confidentiality rules can change and may apply differently depending on a program’s federal status. Speak with a qualified health care provider about any medical decisions, and with an attorney about specific legal questions. Alcohol and benzodiazepine withdrawal can be life-threatening and should only take place under medical supervision.

/by